Microalbuminuria and associated cardiovascular risk factors in the community.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 1596306)

Published in Atherosclerosis on March 01, 1992

Authors

P H Winocour1, J O Harland, J P Millar, M F Laker, K G Alberti

Author Affiliations

1: Department of Medicine, Medical School, University of Newcastle upon Tyne, U.K.

Articles citing this

Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ (1993) 1.45

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38

Microalbuminuria. BMJ (1992) 1.35

High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis (2011) 1.11

Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. J Hypertens (2009) 1.10

Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2008) 1.10

Association between Endothelial Biomarkers and Arterial Elasticity in Young Adults - The CARDIA Study. J Am Soc Hypertens (2010) 0.94

Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care (1999) 0.93

Cardiovascular risk in women with polycystic ovarian syndrome (PCOS). J Clin Pathol (2005) 0.93

Microalbuminuria in inflammatory bowel disease. Gut (1994) 0.93

Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.90

Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population. PLoS One (2013) 0.88

Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol (2000) 0.86

Incidence of microalbuminuria in tobacco chewers. Indian J Clin Biochem (2005) 0.84

Prevalence of microalbuminuria among secondary school children. Afr Health Sci (2012) 0.84

Endothelial function and urine albumin levels among asymptomatic Mexican-Americans and non-Hispanic whites. Cardiovasc Ultrasound (2008) 0.80

Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria. Clin Auton Res (1998) 0.76

Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic. J Clin Pathol (1996) 0.75

Microalbuminuria measured by three different methods, blood pressure and cardiovascular risk factors in elderly Swedish males. Anal Chem Insights (2008) 0.75

Articles by these authors

Global and societal implications of the diabetes epidemic. Nature (2001) 25.18

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40

Local research ethics committees. BMJ (1995) 6.30

Medical errors: a common problem. BMJ (2001) 4.69

Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28

Bone disease after jejuno-ileal bypass for obesity. Lancet (1978) 3.84

Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ (1990) 3.65

Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J (1978) 3.54

Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet (2000) 3.53

Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48

Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34

Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33

Multicentre research ethics committees: has the cure been worse than the disease? No, but idiosyncracies and obstructions to good research must be removed. BMJ (2000) 3.18

Abnormal intestinal permeability to sugars in villous atrophy. Lancet (1979) 3.18

Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem (1978) 2.93

Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia. Lancet (1976) 2.84

Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74

Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet (1989) 2.69

Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58

Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ (1995) 2.57

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J (1978) 2.57

Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens (2000) 2.54

Training in academic medicine: a way forward for the new millennium. A discussion document from the Academic Medicine Committee of the Royal College of Physicians. J R Coll Physicians Lond (1999) 2.42

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41

Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36

Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36

Initial effect of injury on ketone bodies and other blood metabolites. Lancet (1975) 2.27

The management of diabetes during surgery. Br J Anaesth (1979) 2.20

Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med (1990) 2.16

Dangers of intravenous fructose. Lancet (1972) 2.15

Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg (2001) 2.13

Development and validation of a questionnaire for the assessment of physical activity in epidemiological studies in Sub-Saharan Africa. Int J Epidemiol (2001) 2.06

Increase in human intestinal permeability following ingestion of hypertonic solutions. J Physiol (1977) 2.04

The pitfalls of measuring changes in smoking habits. Essential NCD Health Intervention Project Team. Trop Doct (2000) 2.03

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01

Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94

Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92

Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology (1971) 1.86

Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J (1974) 1.82

Occupational status and cardiovascular disease risk factors in the rapidly developing, high-risk population of Mauritius. Am J Epidemiol (1998) 1.75

Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle (1990) 1.75

Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ (1996) 1.72

Insulin dependent diabetes mellitus: a lethal disease in the developing world. BMJ (1994) 1.72

Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr (1998) 1.70

Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care (1994) 1.68

Specificity of hypoglycaemia for cerebral malaria in children. Lancet (1990) 1.68

Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association. Diabet Med (1998) 1.62

Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) (1982) 1.61

Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health (1997) 1.61

Impaired glucose tolerance. BMJ (1990) 1.60

Lung function in patients with diabetes mellitus. Respir Med (1990) 1.59

The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol (2001) 1.57

Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study. BMJ (2000) 1.57

Unsuspected tuberculosis in general hospitals. Lancet (1973) 1.55

The metabolic effects of sodium dichloroacetate in the starved rat. Biochem J (1974) 1.52

Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health (1997) 1.51

Diabetes mellitus: a new look at diagnostic criteria. Diabetologia (1979) 1.49

Low prevalence of risk factors for coronary heart disease in rural Tanzania. Int J Epidemiol (1993) 1.48

Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46

Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46

Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania. BMJ (1991) 1.46

Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46

The effect of acetoacetate on plasma insulin concentration. Biochem J (1971) 1.44

The metabolic effects of quinine in children with severe and complicated Plasmodium falciparum malaria in Dar es Salaam. Trans R Soc Trop Med Hyg (1992) 1.44

Drug therapy for coronary heart disease: the Sheffield table. Lancet (1998) 1.43

Experimental diabetic ketoacidosis. Sequential changes of metabolic intermediates in blood, liver, cerebrospinal fluid and brain after acute insulin deprivation in the streptozotocin-diabetic rat. Biochem J (1974) 1.42

Drug therapy for diabetic dyslipoproteinaemia: a practical approach. Diabet Med (1990) 1.42

Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutation. Diabetes Care (1995) 1.42

Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-dependent diabetes. Lancet (1981) 1.40

Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract (1993) 1.40

Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet (1979) 1.39

Plasma osmolality, iodine concentration and urographic images following high and low osmolar contrast media. Clin Radiol (1991) 1.39

Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function. Q J Med (1994) 1.39

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia (1977) 1.39

Triglycerides in diabetes: time for action? Diabet Med (1994) 1.38

Letter: Metabolic effects of bran. Br Med J (1976) 1.38

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38

Insulin availability among International Diabetes Federation member associations. Report of the Task Force on Insulin Distribution. Diabetes Care (1994) 1.37

Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia (1987) 1.36

Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest (1988) 1.36

Estimation of disaccharides in plasma and urine by gas-liquid chromatography. J Chromatogr (1979) 1.36

Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest (1982) 1.35

Performance of blood-glucose strips. Lancet (1979) 1.34

Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33

Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur J Clin Invest (1975) 1.33

"Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet (1983) 1.33

Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke (1999) 1.32

Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed) (1981) 1.32

Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem J (1990) 1.31

A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med (1999) 1.31

Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med (2000) 1.27

Mannitol estimation in biological fluids by gas-liquid chromatography of trimethylsilyl derivatives. Clin Chem (1980) 1.25

Outlook for survivors of childhood in sub-Saharan Africa: adult mortality in Tanzania. Adult Morbidity and Mortality Project. BMJ (1996) 1.25

Impaired fasting glucose: how low should it go? Diabetes Care (2000) 1.24

Biguanides. Diabetologia (1978) 1.24

Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem (1978) 1.24

Enzymatic measurement of choline-containing phospholipids in bile. J Lipid Res (1981) 1.24

Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health (1999) 1.24

Insulin dependent diabetes in childhood and material deprivation in northern England, 1977-86. BMJ (1991) 1.24